Literature DB >> 11465228

International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?

H Körtke1, R Körfer.   

Abstract

BACKGROUND: Severe thromboembolic and hemorrhagic complications after mechanical heart valve replacement essentially depend on the intensity of oral anticoagulation and the fluctuation of individual international normalized ratio (INR) values.
METHODS: After heart valve replacement with Medtronic Hall, St. Jude Medical, and CarboMedics implants, patients were randomly divided into two groups, one controlling INR values at home, the other being monitored by family practitioners.
RESULTS: Almost 80% of the INR values recorded by patients at home were within the stipulated therapeutic range, INR 2.5 to 4.5, compared with just 62% of INR values recorded by family practitioners. The overall complication rate (hemorrhages and thromboembolic events) of the self-management group was significantly (p < 0.05) decreased compared with the conventional group.
CONCLUSIONS: Through INR self-management, an improvement in the quality of ongoing oral anticoagulation could be shown. Starting this form of therapeutic control early after mechanical heart valve replacement appears to effect a further reduction in anticoagulant-induced complications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465228     DOI: 10.1016/s0003-4975(01)02656-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  27 in total

1.  Twenty-two years without anticoagulation with metallic heart valve.

Authors:  Ali Yildiz; Firat Ozcan; Mehmet Dogan; Mehmet Fatih Ozlü; Ali Sasmaz
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 2.  Oral anticoagulation control: the European perspective.

Authors:  David A Fitzmaurice
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

3.  Quality of warfarin management.

Authors:  Murray Blakes Trusler
Journal:  Can Fam Physician       Date:  2019-08       Impact factor: 3.275

4.  An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS).

Authors:  Rowena J Dolor; R Lynne Ruybalid; Lauren Uyeda; Robert G Edson; Ciaran Phibbs; Julia E Vertrees; Mei-Chiung Shih; Alan K Jacobson; David B Matchar
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

5.  The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS).

Authors:  David B Matchar; Alan K Jacobson; Robert G Edson; Philip W Lavori; Jack E Ansell; Michael D Ezekowitz; Frederick Rickles; Lou Fiore; Kathy Boardman; Ciaran Phibbs; Stephan D Fihn; Julia E Vertrees; Rowena Dolor
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

6.  [Current recommendations for prevention of thromboembolic events in patients with heart valve prostheses].

Authors:  C Gohlke-Bärwolf
Journal:  Z Kardiol       Date:  2001-12

7.  Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study).

Authors:  H Völler; J Glatz; U Taborski; A Bernardo; C Dovifat; K Heidinger
Journal:  Z Kardiol       Date:  2005-03

8.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

9.  Determination of bleeding risk using genetic markers in patients taking phenprocoumon.

Authors:  Eva Hummers-Pradier; Stephan Hess; Ibrahim M Adham; Thomas Papke; Burkert Pieske; Michael M Kochen
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

Review 10.  Anticoagulation for mechanical heart valves: a role for patient based therapy.

Authors:  Robert W Emery; Ann M Emery; Goya V Raikar; Jay G Shake
Journal:  J Thromb Thrombolysis       Date:  2007-12-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.